Round-up
January’s top news stories
Lilly to acquire Dermira for approximately $1.1bn Eli Lilly and Company (Lilly) signed a definitive agreement to acquire biopharmaceutical firm…
November’s top news stories
Novartis to buy The Medicines Company for $9.7bn Novartis signed a definitive agreement to acquire US-based The Medicines Company for…
October’s top news stories
UCB to acquire Ra Pharmaceuticals in $2.1bn deal Belgian biopharmaceutical firm UCB signed a merger agreement to acquire US-based Ra…
August’s top news stories
Bayer agrees to acquire biotech BlueRock for $1bn German multinational pharmaceutical company Bayer signed an agreement to acquire US-based biotechnology…
July’s top news stories
Zirabev gets FDA approval to treat five types of cancer Pfizer secured US Food and Drug Administration (FDA) approval for…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
May’s top news stories
Takeda to divest dry eye drug to Novartis in $5.3bn deal Takeda Pharmaceutical signed an agreement to sell its Xiidra…
April’s top news stories
Novartis to buy IFM Tre for up to $1.57bn Novartis agreed to acquire anti-inflammatory group IFM Tre, a subsidiary of…
February’s top news stories
Top pharma executives testify before US Senate over high prices Top executives from seven major pharmaceutical companies have appeared before the…
January’s top news stories
BMS acquires Celgene for an equity value of $74bn Bristol-Myers Squibb (BMS) has entered into a definitive merger agreement to…
M&As this week: Strides Pharma Science, Lambda Therapeutic Research, NextPharma
Strides Pharma Science’s step-down subsidiary Strides Pharma has made an arrangement to acquire Vensun Pharmaceuticals for $18m. Strides has agreed…